UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Rheumatology

    Many patients with Immune-Mediated Inflammatory Diseases (IMIDs) receive symptomatic treatment, which fails to address their underlying disease. The emergence of comorbidities compounds their cost of care, burdening both IMID patients and the healthcare system at large.

    Patients with axial spondyloarthritis had an average of 4x higher total healthcare costs than the general population.2

    Together we can assess the psoriatic patient’s journey, promote patient-focused care practices, and implement quality measures to create meaningful change.

    Source
    2. Walsh JA, et al, Rheumatol Ther. 2018;5(2):463-474.

    Resources and Quality Measures

    ASCEND Questionnaire

    ASCEND (Assessing Symptoms, Concerns, Experience, and Needs for Decision-making) is a PsA conversation guide intended to facilitate patient-centered dialogue and inform care discussions.

    ASCEND is not a validated tool and should be used as a discussion aid only.

    DOWNLOAD PDF

    Inflammatory Back Pain Questionnaire

    A validated screening tool adapted from ASAS Inflammatory Back Pain criteria for early identification of axial spondyloarthritis (axSpA) patients

    DOWNLOAD PDF

    axSpA ID White Paper

    Report highlighting EHR-integrated screening that improved early axial spondyloarthritis (axSpA) identification and helped close care gaps in community rheumatology.

    DOWNLOAD PDF

    Contact Your Ecosystems Partner for More Information

    EMAIL US

    Wellness4U® Peer-to-Peer Programs

    Explore our wide range of continuing education programs

    SEE PROGRAMS